Distinguished in Hypertension

Dr. Shelley Shapiro

Cardiology
Office
200 Medical Plz Ste 365, 
Los Angeles, CA 
Offers Telehealth

Distinguished in Hypertension
Office
200 Medical Plz Ste 365, 
Los Angeles, CA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Shelley Shapiro is a Cardiologist in Los Angeles, California. Dr. Shapiro is rated as a Distinguished provider by MediFind in the treatment of Hypertension. Her top areas of expertise are Pulmonary Hypertension, Hypertension, Pulmonary Veno-Occlusive Disease, and Blood Clots.

Her clinical research consists of co-authoring 26 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 24 articles and participated in 11 clinical trials in the study of Hypertension.

Specialties
Cardiology
Licenses
Internal Medicine in CA
Hospital Affiliations
Ronald Reagan UCLA Medical Center
Languages Spoken
English
Gender
Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

Office
200 Medical Plz Ste 365, Los Angeles, CA 90095
Call: 310-825-0527
Other Locations
Ronald Reagan UCLA Medical Center
757 Westwood Plz, Los Angeles, CA 90095
Call: 310-825-9111

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


11 Clinical Trials

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Ralinepag When Added to PAH Standard of Care or PAH Specific Background Therapy in Subjects With WHO Group 1 PAH
Enrollment Status: Completed
Publish Date: February 06, 2026
Intervention Type: Drug
Study Drug: Ralinepag
Study Phase: Phase 3
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
An Extended Access Program to Assess Long-term Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Terminated
Publish Date: June 11, 2025
Intervention Type: Drug
Study Phase: Phase 3
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
A Dose-Ranging Study of the Efficacy and Safety of Bardoxolone Methyl in Patients With Pulmonary Hypertension
Enrollment Status: Completed
Publish Date: June 10, 2025
Intervention Type: Drug
Study Phase: Phase 2
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
An Open-label, Clinical Study to Evaluate the Safety and Tolerability of Treprostinil Inhalation Powder (TreT) in Subjects With Pulmonary Arterial Hypertension Currently Using Tyvaso
Enrollment Status: Completed
Publish Date: November 01, 2024
Intervention Type: Drug
Study Drug: Treprostinil Inhalation Powder
Study Phase: Phase 1
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2024
Intervention Type: Drug
Study Drug: AV-101
Study Phase: Phase 2/Phase 3
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
A Phase 3, Randomized, Placebo-controlled, Double-blind, Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Patients With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD)
Enrollment Status: Terminated
Publish Date: November 24, 2023
Intervention Type: Drug
Study Drug: Inhaled treprostinil solution
Study Phase: Phase 3
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
A Randomized, Double-Blind, Parallel Group, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of Once Weekly Subcutaneous (SC) Injections of a Sustained-Release Vasoactive Intestinal Peptide (VIP) Analogue, Pemziviptadil (PB1046), in Adult Subjects With Symptomatic Pulmonary Arterial Hypertension (PAH)
Enrollment Status: Terminated
Publish Date: August 23, 2022
Intervention Type: Drug
Study Drug: Pemziviptadil
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Subjects With Pulmonary Hypertension Due to Parenchymal Lung Disease
Enrollment Status: Completed
Publish Date: July 27, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan: A Prospective Single Center, Open Label, Pilot Study
Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan: A Prospective Single Center, Open Label, Pilot Study
Enrollment Status: Completed
Publish Date: November 02, 2020
Intervention Type: Drug
Study Phase: Phase 4
Using Either Intravenous (IV) or Subcutaneous (SQ) Treprostinil to Treat Pulmonary Hypertension Related to Underlying Interstitial Lung Disease
Using Either Intravenous (IV) or Subcutaneous (SQ) Treprostinil to Treat Pulmonary Hypertension Related to Underlying Interstitial Lung Disease
Enrollment Status: Completed
Publish Date: September 09, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
A Multicenter, Double-blind, Randomized, Placebo-controlled, Phase 3 Study to Assess the Efficacy and Safety of Oral BPS-314d-MR added-on to Treprostinil, Inhaled (Tyvaso®) in Subjects With Pulmonary Arterial Hypertension
Enrollment Status: Completed
Publish Date: August 03, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 10 Less Clinical Trials

26 Total Publications

BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
BREEZE Optional Extension Phase: Long-term safety and efficacy of treprostinil dry powder inhaler (Tyvaso DPI) in pulmonary arterial hypertension.
Journal: Respiratory medicine
Published: June 18, 2025
View All 26 Publications
Similar Doctors
Ronald Oudiz
Distinguished in Hypertension
Dr. Ronald Oudiz
Cardiology
Distinguished in Hypertension
Dr. Ronald Oudiz
Cardiology

Office

21840 Normandie Ave Ste 700, 
Torrance, CA 
 (18.3 miles away)
310-222-5101
Languages Spoken:
English
See accepted insurances

Ronald Oudiz is a Cardiologist in Torrance, California. Dr. Oudiz is rated as a Distinguished provider by MediFind in the treatment of Hypertension. His top areas of expertise are Pulmonary Hypertension, Hypertension, Pulmonary Veno-Occlusive Disease, and Heart Failure.

Distinguished in Hypertension
Dr. Florian Rader
Cardiology
Distinguished in Hypertension
Dr. Florian Rader
Cardiology

Cedars-Sinai Medical Center

127 S San Vicente Blvd, 
Los Angeles,, CA 
 (3.9 miles away)
310-248-7641
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Florian Rader is a Cardiologist in Los Angeles,, California. Dr. Rader is rated as an Elite provider by MediFind in the treatment of Hypertension. His top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Mitral Valve Regurgitation, Cardiomyopathy, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

Distinguished in Hypertension
Dr. Ramandeep K. Brar
Cardiology | Cardiac Electrophysiology
Distinguished in Hypertension
Dr. Ramandeep K. Brar
Cardiology | Cardiac Electrophysiology

Los Alamitos Internal Medical Group Inc

5300 Katella Ave, 
Los Alamitos, CA 
 (29.5 miles away)
562-430-7533
Languages Spoken:
English
See accepted insurances

Ramandeep Brar is a Cardiologist and a Cardiac Electrophysiologist in Los Alamitos, California. Dr. Brar is rated as a Distinguished provider by MediFind in the treatment of Hypertension. Her top areas of expertise are Hypertension, Glucocorticoid-Remediable Aldosteronism, High Cholesterol, Atrial Fibrillation, and Pacemaker Implantation.

VIEW MORE HYPERTENSION DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shapiro's expertise for a condition
ConditionClose
  • Elite
  • Pulmonary Hypertension
    Dr. Shapiro is
    Elite
    . Learn about Pulmonary Hypertension.
    See more Pulmonary Hypertension experts
  • Distinguished
  • Blood Clots
    Dr. Shapiro is
    Distinguished
    . Learn about Blood Clots.
    See more Blood Clots experts
  • Hypertension
    Dr. Shapiro is
    Distinguished
    . Learn about Hypertension.
    See more Hypertension experts
  • Pulmonary Veno-Occlusive Disease
    Dr. Shapiro is
    Distinguished
    . Learn about Pulmonary Veno-Occlusive Disease.
    See more Pulmonary Veno-Occlusive Disease experts
  • Advanced
  • Acute Interstitial Pneumonia
    Dr. Shapiro is
    Advanced
    . Learn about Acute Interstitial Pneumonia.
    See more Acute Interstitial Pneumonia experts
  • Interstitial Lung Disease
    Dr. Shapiro is
    Advanced
    . Learn about Interstitial Lung Disease.
    See more Interstitial Lung Disease experts
  • Systemic Sclerosis (SSc)
    Dr. Shapiro is
    Advanced
    . Learn about Systemic Sclerosis (SSc).
    See more Systemic Sclerosis (SSc) experts
  • Experienced
  • Atrial Fibrillation
    Dr. Shapiro is
    Experienced
    . Learn about Atrial Fibrillation.
    See more Atrial Fibrillation experts
  • Atrial Septal Defect (ASD)
    Dr. Shapiro is
    Experienced
    . Learn about Atrial Septal Defect (ASD).
    See more Atrial Septal Defect (ASD) experts
  • Bronchogenic Cyst
    Dr. Shapiro is
    Experienced
    . Learn about Bronchogenic Cyst.
    See more Bronchogenic Cyst experts
  • Bullae
    Dr. Shapiro is
    Experienced
    . Learn about Bullae.
    See more Bullae experts
  • Congenital Heart Disease (CHD)
    Dr. Shapiro is
    Experienced
    . Learn about Congenital Heart Disease (CHD).
    See more Congenital Heart Disease (CHD) experts
  • Emphysema
    Dr. Shapiro is
    Experienced
    . Learn about Emphysema.
    See more Emphysema experts
View All 18 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.